AMETEK Announces Fourth Quarter 2015 Results

Feb 05, 2016, 06:45 ET from AMETEK, Inc.

BERWYN, Pa., Feb. 5, 2016 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced its financial results for the three month and full year periods ended December 31, 2015.

AMETEK reported fourth quarter 2015 sales of $988.0 million, down 4% from last year's fourth quarter.  Excluding realignment costs of $20.7 million, or $0.06 per diluted share, fourth quarter 2015 operating income was down 1% to $229.5 million, operating margins were up 50 basis points to 23.2%, and diluted earnings per share of $0.63 were unchanged from the fourth quarter 2014 adjusted levels.  Fourth quarter 2014 adjusted results excluded $5.2 million, or $0.01 per diluted share, of Zygo integration costs.

"I am very pleased with AMETEK's results in the fourth quarter and for the full year.  We achieved record levels of operating performance and diluted earnings per share this year despite an increasingly challenging global economic environment.  Our solid results reflect the continued excellent work of all AMETEK colleagues in executing our Four Growth Strategies," noted Frank S. Hermance, AMETEK Chairman and Chief Executive Officer.

On a GAAP basis, fourth quarter 2015 operating income was $208.8 million and diluted earnings per share were $0.57, and fourth quarter 2014 operating income was $227.1 million and diluted earnings per share were $0.62.  A reconciliation of reported GAAP results to adjusted results is included in the financial tables accompanying the release.

Electronic Instruments Group (EIG)

For the fourth quarter of 2015, EIG sales were $628.4 million, down 2% versus $644.4 million in last year's comparable quarter.  Excluding fourth quarter 2015 realignment costs and fourth quarter 2014 Zygo integration costs, operating income increased 2% to a record $170.9 million, and operating margins were up 110 basis points to 27.2%.

"EIG performed well in this slow growth environment.  Lower sales in the quarter were driven by currency headwinds and weakness across our oil and gas businesses.  Our Aerospace business continues to perform well.  Operating performance was very strong with operating margins up 110 basis points benefitting from our focus on Operational Excellence initiatives," added Mr. Hermance.

On a GAAP basis, EIG operating income was $161.7 million in the 2015 fourth quarter and $162.9 million in the 2014 fourth quarter.

Electromechanical Group (EMG)

In the fourth quarter, EMG sales were $359.6 million, down 5% from last year's fourth quarter.  Excluding realignment costs, operating income was down 8% to $70.9 million and operating margins were 19.7% for the quarter.

"EMG managed well through a very difficult market environment in the fourth quarter.  Sales were impacted by foreign currency headwinds and weakness across our Engineered Materials, Interconnects and Packaging businesses largely as a result of continued commodity price deflation," notes Mr. Hermance.

On a GAAP basis, EMG operating income was $60.2 million in the 2015 fourth quarter.

2016 Outlook

"We do not anticipate a meaningful change in global economic conditions in 2016 with sluggish conditions across oil and gas, emerging markets and the broad industrial markets expected to continue.  Despite this, we have proven that our strong portfolio of differentiated businesses, excellent operational capabilities, on-going investments in new product development and geographic expansion, and a continued focus on strategic acquisitions should enable us to perform well in 2016," noted Mr. Hermance.

"We anticipate 2016 revenue to be up low single digits on a percentage basis from 2015.  Earnings for 2016 are expected to be in the range of $2.55 to $2.65 per diluted share, flat to up 4% over 2015 adjusted results," added Mr. Hermance.

"First quarter 2016 sales are expected to be down low single digits from last year's first quarter.  We estimate our earnings to be approximately $0.56 to $0.58 per diluted share," concluded Mr. Hermance.

Conference Call

The Company will webcast its Fourth Quarter 2015 investor conference call on Friday, February 5, 2016 beginning at 8:30 AM ET. The live audio webcast will be available at the Investors section of www.ametek.com and at www.streetevents.com.  The call will also be archived at the Investors section of www.ametek.com.

Corporate Profile

AMETEK is a leading global manufacturer of electronic instruments and electro-mechanical devices with annual sales of $4.0 billion. AMETEK's Corporate Growth Plan is based on Four Key Strategies: Operational Excellence, Strategic Acquisitions, Global & Market Expansion and New Products. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital.  The common stock of AMETEK is a component of the S&P 500 Index.

Forward-looking Information

Statements in this news release relating to future events, such as AMETEK's expected business and financial performance are "forward-looking statements."  Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ significantly from expectations.  These factors and uncertainties include our ability to consummate and successfully integrate future acquisitions; risks associated with international sales and operations; our ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve.  A detailed discussion of these and other factors that may affect our future results is contained in AMETEK's filings with the U.S. Securities and Exchange Commission, including its most recent reports on Form 10-K, 10-Q and 8-K.  AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.

(Financial Information Follows)

 

 

AMETEK, Inc.

Consolidated Statement of Income

(In thousands, except per share amounts)

 Three Months Ended 

 Year Ended 

 December 31, 

 December 31, 

2015

2014

2015

2014

 (Unaudited) 

 (Unaudited) 

 (Unaudited) 

Net sales

$   987,983

$1,024,143

$3,974,295

$4,021,964

Operating expenses:

     Cost of sales, excluding depreciation

647,600

663,463

2,549,280

2,597,017

     Selling, general and administrative

112,890

117,491

448,592

462,637

     Depreciation

18,663

16,105

68,707

63,724

          Total operating expenses 

779,153

797,059

3,066,579

3,123,378

Operating income 

208,830

227,084

907,716

898,586

Other expenses:

     Interest expense

(22,747)

(22,566)

(91,795)

(79,928)

     Other, net

(3,243)

3,016

(9,541)

(13,826)

Income before income taxes

182,840

207,534

806,380

804,832

Provision for income taxes

45,999

55,534

215,521

220,372

Net income

$   136,841

$   152,000

$   590,859

$   584,460

Diluted earnings per share

$        0.57

$        0.62

$        2.45

$        2.37

Basic earnings per share

$        0.58

$        0.62

$        2.46

$        2.39

Weighted average common shares outstanding:

     Diluted shares

238,689

246,132

241,586

247,102

     Basic shares

237,220

243,990

239,906

244,885

Dividends per share

$        0.09

$        0.09

$        0.36

$        0.33

 

 

AMETEK, Inc.

Information by Business Segment

(In thousands)

 Three Months Ended 

 Year Ended 

 December 31, 

 December 31, 

2015

2014

2015

2014

 (Unaudited) 

 (Unaudited) 

 (Unaudited) 

Net sales:

     Electronic Instruments

$   628,415

$   644,386

$2,417,192

$2,421,638

     Electromechanical

359,568

379,757

1,557,103

1,600,326

          Consolidated net sales

$   987,983

$1,024,143

$3,974,295

$4,021,964

Income:

Segment operating income:

     Electronic Instruments

$   161,659

$   162,861

$   639,399

$   612,992

     Electromechanical

60,169

77,032

318,098

335,046

          Total segment operating income

221,828

239,893

957,497

948,038

     Corporate administrative and other expenses

(12,998)

(12,809)

(49,781)

(49,452)

          Consolidated operating income

$   208,830

$   227,084

$   907,716

$   898,586

 

 

AMETEK, Inc.

Condensed Consolidated Balance Sheet

(In thousands)

 December 31, 

 December 31, 

2015

2014

 (Unaudited) 

ASSETS

Current assets:

     Cash and cash equivalents

$     381,005

$     377,615

     Receivables, net

603,295

585,462

     Inventories, net

514,451

495,896

     Other current assets

120,862

119,631

          Total current assets

1,619,613

1,578,604

Property, plant and equipment, net

484,548

448,446

Goodwill

2,706,633

2,614,030

Other intangibles, investments and other assets

1,853,736

1,779,883

          Total assets

$  6,664,530

$  6,420,963

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

     Short-term borrowings and current portion of long-term debt

$     386,075

$     286,201

     Accounts payable and accruals

639,097

649,943

          Total current liabilities

1,025,172

936,144

Long-term debt

1,556,045

1,427,825

Deferred income taxes and other long-term liabilities

828,687

817,433

Stockholders' equity

3,254,626

3,239,561

          Total liabilities and stockholders' equity

$  6,664,530

$  6,420,963

 

 

AMETEK, Inc.

Reconciliations of GAAP to Non-GAAP Financial Measures

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended

Year Ended

December 31,

December 31,

2015

2014

2015

2014

EIG Segment operating income (GAAP)

$   161,659

$   162,861

$   639,399

$   612,992

Realignment costs

9,267

-

18,518

-

Zygo integration costs

-

5,222

-

18,877

Adjusted EIG Segment operating income (Non-GAAP)

$   170,926

$   168,083

$   657,917

$   631,869

EMG Segment operating income (GAAP)

$     60,169

$     77,032

$   318,098

$   335,046

Realignment costs

10,764

-

17,298

-

Adjusted EMG Segment operating income (Non-GAAP)

$     70,933

$     77,032

$   335,396

$   335,046

Operating income (GAAP)

$   208,830

$   227,084

$   907,716

$   898,586

Realignment costs

20,711

-

36,605

-

Zygo integration costs

-

5,222

-

18,877

Adjusted Operating income (Non-GAAP)

$   229,541

$   232,306

$   944,321

$   917,463

Net income (GAAP)

$   136,841

$   152,000

$   590,859

$   584,460

Realignment costs

13,868

(1)

-

24,676

(2)

-

Zygo integration costs

-

3,177

(3)

-

13,894

(4)

Adjusted Net income (Non-GAAP)

$   150,709

$   155,177

$   615,535

$   598,354

(1) Represents adjustments at 33.0% tax rate.

(2) Represents adjustments at 32.6% tax rate.

(3) Represents adjustments at 39.2% tax rate.

(4) Represents adjustments at 26.4% tax rate.

Diluted earnings per share (GAAP)

$         0.57

$         0.62

$         2.45

$         2.37

Realignment costs

0.06

-

0.10

-

Zygo integration costs

-

0.01

-

0.05

Adjusted Diluted earnings per share (Non-GAAP)

$         0.63

$         0.63

$         2.55

$         2.42

EIG Segment operating margin (GAAP)

25.7%

25.3%

26.5%

25.3%

Realignment costs

1.5

-

0.7

-

Zygo integration costs

-

0.8

-

0.8

Adjusted EIG Segment operating margin (Non-GAAP)

27.2%

26.1%

27.2%

26.1%

EMG Segment operating margin (GAAP)

16.7%

20.3%

20.4%

20.9%

Realignment costs

3.0

-

1.1

-

Adjusted EMG Segment operating margin (Non-GAAP)

19.7%

20.3%

21.5%

20.9%

Operating income margin (GAAP)

21.1%

22.2%

22.8%

22.3%

Realignment costs

2.1

-

1.0

-

Zygo integration costs

-

0.5

-

0.5

Adjusted Operating income margin (Non-GAAP)

23.2%

22.7%

23.8%

22.8%

 

 

Use of Non-GAAP Financial Information

The Company supplements its consolidated financial statements presented on a U.S. generally accepted accounting principles ("GAAP") basis with certain non‑GAAP financial information to provide investors with greater insight, increased transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making.  Reconciliation of non‑GAAP measures to their most directly comparable GAAP measures are included in the accompanying financial tables. These non‑GAAP financial measures should be considered in addition to, and not as a replacement for, or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.

The Company believes that these measures provide useful information to investors by reflecting additional ways of viewing AMETEK's operations that, when reconciled to the comparable GAAP measure, helps our investors to better understand the long-term profitability trends of our business, and facilitates easier comparisons of our profitability to prior and future periods and to our peers.  The items described above have been excluded from this measure because items of this nature and/or size occur with inconsistent frequency, occur for reasons that may be unrelated to AMETEK's commercial performance during the period and/or we believe are not indicative of AMETEK's ongoing operating costs or gains in a given period, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult.

Contact: Kevin Coleman +1 610-889-5247

SOURCE AMETEK, Inc.



RELATED LINKS

http://www.ametek.com